Amylin to be ACQUIRED by Brystol-Myers Squibb and 4 Stocks that Have Hit 52-Week Highs
Abbott Laboratories (NYSE:ABT) and Natural Alternatives International (NASDAQ:NAII) report that they have jointly agreed to an amendment to their License and Supply Agreement. Under the terms, as previously amended, Abbott maintained the right to terminate the Agreement at any time up to July 31st. Under the new Amendment, the due date remains the same for the payment of the remaining $354,167 of the initial installment of additional license fees, but NAI has granted Abbott an extension until October 31, of Abbott’s rights to terminate. As a result, Abbott now has the option to end the Agreement at any time before October 31, notwithstanding the payment of the initial installment amount. Shares closed up 0.09 percent on the day at $65.67, having traded between $46.29 and $65.63 for the past 52 weeks.
Amylin Pharmaceutica (NASDAQ:AMLN) is being acquired by Bristol-Myers Squibb (NYSE:BMY), through its wholly owned subsidiary B&R Acquisition Company, by a cash tender offer to purchase all outstanding shares of common stock of Amylin. Bristol-Myers Squibb announced on June 29th its intention to purchase Amylin, and with the successful closing of the tender offer, Amylin stockholders will receive $31.00 in cash for each share of Amylin common stock validly tendered but not validly withdrawn in the offer, without interest and excluding any applicable withholding taxes. Amylin will become a subsidiary of Bristol-Myers Squibb, subsequent to the purchase of shares in the tender offer. Shares closed up 0.13 percent on the day at $30.78, having traded between $8.03 and $30.79 the past 52 weeks.
American Tower Corp. (NYSE:AMT) shares closed down 2.67 percent on the day at $69.90, having been traded in a 52-week range of $46.04 to $71.94.
Asml Holding N.V. (NASDAQ:ASML), provider to chipmakers of machines, made a proposal to contract chip maker TSMC on co-investment and the latter is in the process of evaluating the proposal, according to Reuters. Shares closed up 8.48 percent on the day at $52.57, having traded between $30.65 and $52.87 the past 52 weeks.
Center Bancorp (NASDAQ:CNBC), parent company of Union Center National Bank, revealed that the latter has been granted approval by the Office of the Comptroller of the Currency to consummate its purchase of substantially all of the assets and assumption of substantially all of the liabilities of Saddle River Valley Bank, based in Saddle River, New Jersey and from then to operate its Saddle River and Oakland branches as branches of UCNB. The transaction remains subject to addional conditions and approval requirements; closing of the transaction should be finalized in the third quarter. Shares closed up 0.26 percent on the day at $11.47, having traded between $8.40 and $11.48 in the past 52 weeks.
Don’t Miss: Is Apple Completely Re-Designing the iPod?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.